SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001651308-24-000034
Filing Date
2024-03-26
Accepted
2024-03-26 17:26:42
Documents
3
Period of Report
2024-03-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1711488380.html 3  
1 FORM 3 wk-form3_1711488380.xml 3 3707
2 EX-24 ball-poa.htm EX-24 4816
3 GRAPHIC ball-poa001.jpg GRAPHIC 290132
  Complete submission text file 0001651308-24-000034.txt   409751
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Issuer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 11605 NORTH COMMUNITY HOUSE ROAD SUITE 600 CHARLOTTE NC 28277
Business Address
Ball Titus B. (Reporting) CIK: 0001675628 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37686 | Film No.: 24784812